Yangtze River's Sales Rise 36 Percent To RMB 25 Billion Last Year
This article was originally published in PharmAsia News
Executive Summary
In 2010, Yangtze River Pharmaceutical Group achieved RMB 25.016 billion in sales and 25.168 in production, both climbing over 36 percent
You may also be interested in...
New Filings At The EMA
New medicines under evaluation at the European Medicines Agency.
Merz Consumer Care Optimistic About Future As German Lockdown Continues
Will the second wave of coronavirus lockdown have the same impact on the European consumer health industry? Speaking exclusively to HBW Insight from Germany, Merz Consumer Care CEO Frank Baldauf thinks not. Recently investing in premium beard care brand Brooklyn Soap and launching its tetesept Formula range in the Netherlands, Merz's Baldauf suggest that there will be less panic buying this time round and the CHC supply chain will hold up under pressure.
Towa Plans 10 Launches In December 2020
After a strong first quarter, Japan’s Towa Pharmaceuticals saw stability in its domestic revenues but a drop in revenues from its overseas business in its financial second quarter. After launching a series of molecules in June 2020, the company has lined up 10 launches for December 2020 as well.
Need a specific report? 1000+ reports available
Buy Reports